A simulation study of the cost of cerebral vasospasm treatments with clazosentan: A mathematical model using time-driven activity-based costing
Fig 5
Impact of clazosentan effectiveness on total cost.
Each data point represents results for 10,000 hypothetical patients undergoing each treatment pathway as modelled in the decision tree. This process was repeated with 1,000 iterations to estimate the mean and 95% credible intervals. Claz, clazosentan; sVSP, symptomatic vasospasm; SD, standard deviation.